Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Disease area: Airway diseases

Abstract

Neutrophils play an appreciable role in reactions of local immunity at COPD. The aim of our study was to examine the concentration of the reactive carbonyl derivatives of proteins (RCD) in neutrophils at patients with varying severity of COPD. COPD exacerbations with development of respiratory failure had accompanied by the syndrome of bronchial obstruction at all patients. The 1 group (n = 29) included patients with COPD moderate severity, mixed form (emphysematous and bronchial). The 2 group (n = 21) consisted of patients with COPD, severe, mixed form. Group 3 (n = 35) included patients with COPD, moderate, bronchial type. Group 4 (n = 23) included patients with COPD, severe, bronchial type. In control group there were 32 healthy ones. All patients and healthy subjects had given their consent to participate. The RCD was measured in cells following the protocol of R.L. Levine et al. (1990).
RCD level in neutrophils of patients with mixed form of COPD was lower compared with controls ones (p<0,05). RCD level in neutrophils of patients with bronchial type of COPD was higher compared with controls ones (p<0,001) and depended on COPD severity. Such kind of imbalance of protein carbonylation in neutrophils at restrictive and obstructive ventilatory dysfunction phenomenon may be considered as a one of the possible trigger factor and predictor of severe progressive course of COPD.

Rating:

Share or cite this content

Citations should be made in the following way:
V. Molotov-Luchanskiy, L. Muravluyova, D. Kluyev (Karaganda, Kazakhstan). The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD. Eur Respir J 2013; 42: Suppl. 57, 257

Member's Comments

No comment yet.

Related content which might interest you: Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Redox systems of neutrophils of patients with exacerbated COPD Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Methylated arginine derivatives can differ stable and unstable patients with COPD Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015